Latest filing published 31 Jul 2018 for Oasmia Pharmaceutical AB, €4,452.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Richard Herrmann: trading record in brief
Richard Herrmann discloses dealings in Oasmia Pharmaceutical AB to Finansinspektionen. Between 25 January 2018 and 27 July 2018, the trades on record add up to 4 filings.
The open-market record is one-sided, with 4 purchases worth €11k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €2,627. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 31 July 2018 came the latest disclosure, an open-market purchase for €4,452 in Oasmia Pharmaceutical AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Herrmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ SEK 5.7138.9% of flowISIN SE0000722365FI:csv-a7ca9749e2a2458a8435Canonical exit: 25 Oct 2018 (T+90)
- 3,000 shares@ SEK 6.0015.2% of flowISIN SE0000722365FI:csv-7fd4da0255747f57e871Canonical exit: 22 Oct 2018 (T+90)
- 7,500 shares@ SEK 3.5323.5% of flowISIN SE0000722365FI:csv-a6460b92e8f7f736e4f4Canonical exit: 26 Apr 2018 (T+90)
- 7,500 shares@ SEK 3.35522.4% of flowISIN SE0000722365FI:csv-7b4c45896534540dd3deCanonical exit: 25 Apr 2018 (T+90)
4 of 4 declarations